Clipmarks
   
  
   
Matthew Herperfollowshare
6-4-2008 9:19 PM
925 views
The weak dollar strikes again, as another U.S.-based biotech gets bought by an overseas drugmaker. Ipsen already owned 25% of Tercica, which makes a hormone for treating children who are not growing adequately. Still, that 104% premium is pretty eye-catching.
Login to Comment.  Not a member yet? Sign up
Embed This Clip In Your Site...

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!

OK